My Bibliography

select

Holloway RW, Thaker P, Mendivil AA, Ahmad S, Al-Niaimi AN, Barter J, Beck T, Chambers SK, Coleman RL, Crafton SM, Crane E, Ramez E, Ghamande S, Graybill W, Herzog T, Indermaur MD, John VS, Landrum L, Lim PC, Lucci JA, McHale M, Monk BJ, Moore KN, Morris R, O'Malley DM, Reid TJ, Richardson D, Rose PG, Scalici JM, Silasi DA, Tewari K, Wang EW. A phase III, multicenter, randomized study of olvimulogene nanivacirepvec followed by platinum-doublet chemotherapy and bevacizumab compared with platinum-doublet chemotherapy and bevacizumab in women with platinum-resistant/refractory ovarian cancer. Int J Gynecol Cancer. 2023 Sep 4;33(9):1458-1463. doi: 10.1136/ijgc-2023-004812. PubMed PMID: 37666539.

select

Anandhan A, Dodson M, Shakya A, Chen J, Liu P, Wei Y, Tan H, Wang Q, Jiang Z, Yang K, Garcia JG, Chambers SK, Chapman E, Ooi A, Yang-Hartwich Y, Stockwell BR, Zhang DD. NRF2 controls iron homeostasis and ferroptosis through HERC2 and VAMP8. Sci Adv. 2023 Feb 3;9(5):eade9585. doi: 10.1126/sciadv.ade9585. Epub 2023 Feb 1. PubMed PMID: 36724221; PubMed Central PMCID: PMC9891695.

select

Tanyi JL, Randall LM, Chambers SK, Butler KA, Winer IS, Langstraat CL, Han ES, Vahrmeijer AL, Chon HS, Morgan MA, Powell MA, Tseng JH, Lopez AS, Wenham RM. A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor-Positive Ovarian Cancer (Study 006). J Clin Oncol. 2023 Jan 10;41(2):276-284. doi: 10.1200/JCO.22.00291. Epub 2022 Sep 7. PubMed PMID: 36070540.

select

Chambers SK. Advances in Chemotherapy and Targeted Therapies in Endometrial Cancer. Cancers (Basel). 2022 Oct 14;14(20). doi: 10.3390/cancers14205020. PubMed PMID: 36291804; PubMed Central PMCID: PMC9599945.

select

Yu X, Lin W, Spirtos A, Wang Y, Chen H, Ye J, Parker J, Liu CC, Wang Y, Quinn G, Zhou F, Chambers SK, Lewis C, Lea J, Li B, Zheng W. Dissection of transcriptome dysregulation and immune characterization in women with germline BRCA1 mutation at single-cell resolution. BMC Med. 2022 Sep 9;20(1):283. doi: 10.1186/s12916-022-02489-9. PubMed PMID: 36076202; PubMed Central PMCID: PMC9461201.

select

Moore KN, Chambers SK, Hamilton EP, Chen LM, Oza AM, Ghamande SA, Konecny GE, Plaxe SC, Spitz DL, Geenen JJJ, Troso-Sandoval TA, Cragun JM, Rodrigo Imedio E, Kumar S, Mugundu GM, Lai Z, Chmielecki J, Jones SF, Spigel DR, Cadoo KA. Adavosertib with Chemotherapy in Patients with Primary Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer: An Open-Label, Four-Arm, Phase II Study. Clin Cancer Res. 2022 Jan 1;28(1):36-44. doi: 10.1158/1078-0432.CCR-21-0158. Epub 2021 Oct 13. PubMed PMID: 34645648.

select

Woo HH, Chambers SK. Regulation of closely juxtaposed proto-oncogene c-fms and HMGXB3 gene expression by mRNA 3' end polymorphism in breast cancer cells. RNA. 2021 Sep;27(9):1068-1081. doi: 10.1261/rna.078749.121. Epub 2021 Jun 21. PubMed PMID: 34155128; PubMed Central PMCID: PMC8370744.

select

Swisher EM, Kwan TT, Oza AM, Tinker AV, Ray-Coquard I, Oaknin A, Coleman RL, Aghajanian C, Konecny GE, O'Malley DM, Leary A, Provencher D, Welch S, Chen LM, Wahner Hendrickson AE, Ma L, Ghatage P, Kristeleit RS, Dorigo O, Musafer A, Kaufmann SH, Elvin JA, Lin DI, Chambers SK, Dominy E, Vo LT, Goble S, Maloney L, Giordano H, Harding T, Dobrovic A, Scott CL, Lin KK, McNeish IA. Molecular and clinical determinants of response and resistance to rucaparib for recurrent ovarian cancer treatment in ARIEL2 (Parts 1 and 2). Nat Commun. 2021 May 3;12(1):2487. doi: 10.1038/s41467-021-22582-6. PubMed PMID: 33941784; PubMed Central PMCID: PMC8093258.

select

Sawyer TW, Koevary JW, Howard CC, Austin OJ, Rice PFS, Hutchens GV, Chambers SK, Connolly DC, Barton JK. Fluorescence and Multiphoton Imaging for Tissue Characterization of a Model of Postmenopausal Ovarian Cancer. Lasers Surg Med. 2020 Dec;52(10):993-1009. doi: 10.1002/lsm.23251. Epub 2020 Apr 20. PubMed PMID: 32311117; PubMed Central PMCID: PMC7572562.

select

Tao T, Lin W, Wang Y, Zhang J, Chambers SK, Li B, Lea J, Wang Y, Wang Y, Zheng W. Loss of tubal ciliated cells as a risk for "ovarian" or pelvic serous carcinoma. Am J Cancer Res. 2020;10(11):3815-3827. eCollection 2020. PubMed PMID: 33294269; PubMed Central PMCID: PMC7716167.

select

Woo HH, Chambers SK. The alternative spliced 3'-UTR mediated differential secretion of macrophage colony stimulating factor in breast cancer cells. Biochem Biophys Res Commun. 2020 May 14;525(4):1004-1010. doi: 10.1016/j.bbrc.2020.03.007. Epub 2020 Mar 13. PubMed PMID: 32178869.

select

Pandey R, Woo HH, Varghese F, Zhou M, Chambers SK. Circulating miRNA Profiling of Women at High Risk for Ovarian Cancer. Transl Oncol. 2019 May;12(5):714-725. doi: 10.1016/j.tranon.2019.01.006. Epub 2019 Mar 9. PubMed PMID: 30856556; PubMed Central PMCID: PMC6411608.

select

Hoyer PB, Rice PF, Howard CC, Koevary JW, Dominguez Cooks JP, Hutchens GV, Chambers SK, Craig ZR, Connolly DC, Barton JK. Comparison of Reproductive Function in Female TgMISIIR-TAg Transgenic and Wildtype C57BL/6 Mice. Comp Med. 2019 Feb 1;69(1):16-21. doi: 10.30802/AALAS-CM-18-000008. Epub 2018 Dec 27. PubMed PMID: 30591091; PubMed Central PMCID: PMC6382048.

select

Lin KK, Harrell MI, Oza AM, Oaknin A, Ray-Coquard I, Tinker AV, Helman E, Radke MR, Say C, Vo LT, Mann E, Isaacson JD, Maloney L, O'Malley DM, Chambers SK, Kaufmann SH, Scott CL, Konecny GE, Coleman RL, Sun JX, Giordano H, Brenton JD, Harding TC, McNeish IA, Swisher EM. BRCA Reversion Mutations in Circulating Tumor DNA Predict Primary and Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma. Cancer Discov. 2019 Feb;9(2):210-219. doi: 10.1158/2159-8290.CD-18-0715. Epub 2018 Nov 13. PubMed PMID: 30425037.

select

Woo HH, Lee SC, Stoffer JB, Rush D, Chambers SK. Phenotype of vigilin expressing breast cancer cells binding to the 69 nt 3'UTR element in CSF-1R mRNA. Transl Oncol. 2019 Jan;12(1):106-115. doi: 10.1016/j.tranon.2018.09.012. Epub 2018 Oct 3. PubMed PMID: 30292064; PubMed Central PMCID: PMC6171096.

select

Woo HH, Chambers SK. Human ALKBH3-induced m(1)A demethylation increases the CSF-1 mRNA stability in breast and ovarian cancer cells. Biochim Biophys Acta Gene Regul Mech. 2019 Jan;1862(1):35-46. doi: 10.1016/j.bbagrm.2018.10.008. Epub 2018 Oct 17. PubMed PMID: 30342176.

select

Fader AN, Roque DM, Siegel E, Buza N, Hui P, Abdelghany O, Chambers SK, Secord AA, Havrilesky L, O'Malley DM, Backes F, Nevadunsky N, Edraki B, Pikaart D, Lowery W, ElSahwi KS, Celano P, Bellone S, Azodi M, Litkouhi B, Ratner E, Silasi DA, Schwartz PE, Santin AD. Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu. J Clin Oncol. 2018 Jul 10;36(20):2044-2051. doi: 10.1200/JCO.2017.76.5966. Epub 2018 Mar 27. PubMed PMID: 29584549.

select

Coleman RL, Oza AM, Lorusso D, Aghajanian C, Oaknin A, Dean A, Colombo N, Weberpals JI, Clamp A, Scambia G, Leary A, Holloway RW, Gancedo MA, Fong PC, Goh JC, O'Malley DM, Armstrong DK, Garcia-Donas J, Swisher EM, Floquet A, Konecny GE, McNeish IA, Scott CL, Cameron T, Maloney L, Isaacson J, Goble S, Grace C, Harding TC, Raponi M, Sun J, Lin KK, Giordano H, Ledermann JA. Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2017 Oct 28;390(10106):1949-1961. doi: 10.1016/S0140-6736(17)32440-6. Epub 2017 Sep 12. PubMed PMID: 28916367; PubMed Central PMCID: PMC5901715.

select

Jones KM, Randtke EA, Yoshimaru ES, Howison CM, Chalasani P, Klein RR, Chambers SK, Kuo PH, Pagel MD. Clinical Translation of Tumor Acidosis Measurements with AcidoCEST MRI. Mol Imaging Biol. 2017 Aug;19(4):617-625. doi: 10.1007/s11307-016-1029-7. PubMed PMID: 27896628; PubMed Central PMCID: PMC6010170.

select

Chen H, Klein R, Arnold S, Wang Y, Chambers S, Zheng W. Tubal Cytology of the Fallopian Tube as a Promising Tool for Ovarian Cancer Early Detection. J Vis Exp. 2017 Jul 25;(125). doi: 10.3791/55887. PubMed PMID: 28784945; PubMed Central PMCID: PMC5612597.

select

Sinharay S, Randtke EA, Jones KM, Howison CM, Chambers SK, Kobayashi H, Pagel MD. Noninvasive detection of enzyme activity in tumor models of human ovarian cancer using catalyCEST MRI. Magn Reson Med. 2017 May;77(5):2005-2014. doi: 10.1002/mrm.26278. Epub 2016 May 25. PubMed PMID: 27221386; PubMed Central PMCID: PMC5123981.

select

Woo HH, Lee SC, Gibson SJ, Chambers SK. Expression of the cytoplasmic nucleolin for post-transcriptional regulation of macrophage colony-stimulating factor mRNA in ovarian and breast cancer cells. Biochim Biophys Acta Gene Regul Mech. 2017 Mar;1860(3):337-348. doi: 10.1016/j.bbagrm.2017.01.006. Epub 2017 Jan 25. PubMed PMID: 28131007.

select

Chen H, Klein R, Arnold S, Chambers S, Zheng W. Cytologic studies of the fallopian tube in patients undergoing salpingo-oophorectomy. Cancer Cell Int. 2016;16:78. doi: 10.1186/s12935-016-0354-x. eCollection 2016. PubMed PMID: 27733814; PubMed Central PMCID: PMC5045608.

select

Wang X, Li L, Cragun JM, Chambers SK, Hatch KD, Zheng W. Assessment of the Role of Intraoperative Frozen Section in Guiding Surgical Staging for Endometrial Cancer. Int J Gynecol Cancer. 2016 Jun;26(5):918-23. doi: 10.1097/IGC.0000000000000692. PubMed PMID: 27051054.

select

Tate TH, Baggett B, Rice PF, Koevary JW, Orsinger GV, Nymeyer AC, Welge WA, Saboda K, Roe DJ, Hatch KD, Chambers SK, Utzinger U, Barton JK. Multispectral fluorescence imaging of human ovarian and fallopian tube tissue for early-stage cancer detection. J Biomed Opt. 2016 May 1;21(5):56005. doi: 10.1117/1.JBO.21.5.056005. PubMed PMID: 27220626; PubMed Central PMCID: PMC5996865.

select

Wang Y, Wang Y, Zhang Z, Park JY, Guo D, Liao H, Yi X, Zheng Y, Zhang D, Chambers SK, Zheng W. Mechanism of progestin resistance in endometrial precancer/cancer through Nrf2-AKR1C1 pathway. Oncotarget. 2016 Mar 1;7(9):10363-72. doi: 10.18632/oncotarget.7004. PubMed PMID: 26824415; PubMed Central PMCID: PMC4891125.

select

Risi MD, Rouse AR, Chambers SK, Hatch KD, Zheng W, Gmitro AF. Pilot Clinical Evaluation of a Confocal Microlaparoscope for Ovarian Cancer Detection. Int J Gynecol Cancer. 2016 Feb;26(2):248-54. doi: 10.1097/IGC.0000000000000595. PubMed PMID: 26745695; PubMed Central PMCID: PMC4728032.

select

Hess LM, Huang HQ, Hanlon AL, Robinson WR, Johnson R, Chambers SK, Mannel RS, Puls L, Davidson SA, Method M, Lele S, Havrilesky L, Nelson T, Alberts DS. Cognitive function during and six months following chemotherapy for front-line treatment of ovarian, primary peritoneal or fallopian tube cancer: An NRG oncology/gynecologic oncology group study. Gynecol Oncol. 2015 Dec;139(3):541-5. doi: 10.1016/j.ygyno.2015.10.003. Epub 2015 Oct 9. PubMed PMID: 26456812; PubMed Central PMCID: PMC4698796.

select

Baker AF, Malm SW, Pandey R, Laughren C, Cui H, Roe D, Chambers SK. Evaluation of a hypoxia regulated gene panel in ovarian cancer. Cancer Microenviron. 2015 Apr;8(1):45-56. doi: 10.1007/s12307-015-0166-x. Epub 2015 May 22. PubMed PMID: 25998313; PubMed Central PMCID: PMC4449346.

select

Ferguson D, Han L, Wang Y, Cragun J, Hatch K, Chambers S, Zheng W. The role of the fallopian tube in ovarian serous carcinogenesis: biologic mechanisms and clinical impacts. American journal of clinical and experimental obstetrics and gynecology. 2015; 2(1):XXX-XXX (July 2015).

select

Wu TY, Rouse AR, Chambers SK, Hatch KD, Gmitro AF. Confocal microlaparoscope for imaging the fallopian tube. J Biomed Opt. 2014 Nov;19(11):116010. doi: 10.1117/1.JBO.19.11.116010. PubMed PMID: 25411899; PubMed Central PMCID: PMC4409019.

select

Gruessner C, Gruessner A, Glaser K, AbuShahin N, Zhou Y, Laughren C, Wright H, Pinkerton S, Yi X, Stoffer J, Azodi M, Zheng W, Chambers SK. Flutamide and biomarkers in women at high risk for ovarian cancer: preclinical and clinical evidence. Cancer Prev Res (Phila). 2014 Sep;7(9):896-905. doi: 10.1158/1940-6207.CAPR-13-0408. Epub 2014 Jun 20. PubMed PMID: 24950779; PubMed Central PMCID: PMC4154987.

select

Yuan Z, Wang L, Wang Y, Zhang T, Li L, Cragun JM, Chambers SK, Kong B, Zheng W. Tubal origin of ovarian endometriosis. Mod Pathol. 2014 Aug;27(8):1154-62. doi: 10.1038/modpathol.2013.245. Epub 2014 Jan 3. PubMed PMID: 24390223.

select

Coleman RL, Moon J, Sood AK, Hu W, Delmore JE, Bonebrake AJ, Anderson GL, Chambers SK, Markman M. Randomised phase II study of docetaxel plus vandetanib versus docetaxel followed by vandetanib in patients with persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: SWOG S0904. Eur J Cancer. 2014 Jun;50(9):1638-48. doi: 10.1016/j.ejca.2014.03.005. Epub 2014 Apr 4. PubMed PMID: 24709487; PubMed Central PMCID: PMC4098779.

select

Jeffery JJ, Lux K, Vogel JS, Herrera WD, Greco S, Woo HH, AbuShahin N, Pagel MD, Chambers SK. Autocrine inhibition of the c-fms proto-oncogene reduces breast cancer bone metastasis assessed with in vivo dual-modality imaging. Exp Biol Med (Maywood). 2014 Apr;239(4):404-13. doi: 10.1177/1535370214522588. Epub 2014 Mar 5. PubMed PMID: 24599884; PubMed Central PMCID: PMC4882610.

select

Orsinger GV, Watson JM, Gordon M, Nymeyer AC, de Leon EE, Brownlee JW, Hatch KD, Chambers SK, Barton JK, Kostuk RK, Romanowski M. Simultaneous multiplane imaging of human ovarian cancer by volume holographic imaging. J Biomed Opt. 2014 Mar;19(3):36020. doi: 10.1117/1.JBO.19.3.036020. PubMed PMID: 24676382; PubMed Central PMCID: PMC3967775.

select

Gruessner C, Gruessner A, Glaser K, Abushahin N, Laughren C, Zheng W, Chambers SK. Biomarkers and endosalpingiosis in the ovarian and tubal microenvironment of women at high-risk for pelvic serous carcinoma. Am J Cancer Res. 2014;4(1):61-72. eCollection 2014. PubMed PMID: 24482739; PubMed Central PMCID: PMC3902233.

select

Chen C, Li J, Yao G, Chambers SK, Zheng W. Tubal origin of ovarian low-grade serous carcinoma. Am J Clin Exp Obstet Gynecol. 2013 Dec 15;1(1):13-36. PubMed PMID: 25346935; PubMed Central PMCID: PMC4205570.

select

Cragun J, Baggs J, Rollins C, Chambers S. 4. Hypersensitivity Reaction to Parenteral Nutrition after Severe Hypersensitivity Reaction to Paclitaxel: a case report. Amer J Clin Exp Obstet Gynecol. 2013 December; 1(1):69-75.

select

Li J, Ning Y, Abushahin N, Yuan Z, Wang Y, Wang Y, Yuan B, Cragun JM, Chambers SK, Hatch K, Kong B, Zheng W. Secretory cell expansion with aging: risk for pelvic serous carcinogenesis. Gynecol Oncol. 2013 Dec;131(3):555-60. doi: 10.1016/j.ygyno.2013.09.018. Epub 2013 Sep 20. PubMed PMID: 24060413.

select

Woo HH, Baker T, Laszlo C, Chambers SK. Nucleolin mediates microRNA-directed CSF-1 mRNA deadenylation but increases translation of CSF-1 mRNA. Mol Cell Proteomics. 2013 Jun;12(6):1661-77. doi: 10.1074/mcp.M112.025288. Epub 2013 Mar 7. PubMed PMID: 23471483; PubMed Central PMCID: PMC3675821.

select

Wang Y, Wang Y, Li J, Cragun J, Hatch K, Chambers SK, Zheng W. Lynch syndrome related endometrial cancer: clinical significance beyond the endometrium. J Hematol Oncol. 2013 Mar 25;6:22. doi: 10.1186/1756-8722-6-22. PubMed PMID: 23531335; PubMed Central PMCID: PMC3623651.

select

Nelson-Moseke AC, Jeter JM, Cui H, Roe DJ, Chambers SK, Laukaitis CM. An unusual BRCA mutation distribution in a high risk cancer genetics clinic. Fam Cancer. 2013 Mar;12(1):83-7. doi: 10.1007/s10689-012-9581-z. PubMed PMID: 23179792; PubMed Central PMCID: PMC3563940.

select

Baker AF, Roe DJ, Laughren C, Cohen JL, Wright HM, Clouser MC, Cui H, Alberts DS, Chambers SK. Investigation of bendamustine HCL in a phase 2 study in women with resistant ovarian cancer. Invest New Drugs. 2013 Feb;31(1):160-6. doi: 10.1007/s10637-012-9827-5. Epub 2012 May 13. PubMed PMID: 22580577; PubMed Central PMCID: PMC3988024.

select

Chambers S, Hess L. Fundamentals of Cancer Prevention. In: Hess A, editor. Ovarian Cancer Prevention Third ed. Heidelberg: Springer-Verlag; 2013.

select

Yuan Z, Wang Y, Cragun J, Chambers S, Zheng W. W.Cell Origin of Endometriosis: Origin of Endometriosis. Amer J Clin Exp Obstet Gynecol. 2013; 1(1):37-42.

select

Chambers S, Joiner K. Current Multidisciplinary Oncology. In: Thomas C, Odunsi K, Pejovic T, editors. Incorporating translational research into gynecologic cancers, while balancing the focus of personalized medicine New York: Demos Medical Publishing; 2013.

select

Woo H, Chambers S. Post-transcriptional regulation of proto-oncogene c-fms in breast cancer. In: Siregar Y, editor. Oncogene and Cancer from Bench to Clinic Rijeka, Croatia: InTech Open Access Publishers; 2013. Chapter 13.

select

Chambers S, Zheng W, Adashi E, Hatch K, Kong B, Plaxe S, Silver R. Launch of American Journal of Clinical and Experimental Obstetrics and Gynecology. Am J Clin Exp Obstet Gynecol. 2013; 1(1).

select

Han L, Ferguson D, Chambers S, Fadare O, Wang Y, Zheng W. From Endometrial Glandular Dysplasia to Endometrial Serous Carcinoma: Insights into Underlying Biological Aspects. Amer J Clin Exp Obstet Gynecol. 2013; 1(1):1-16.